RESUMO
Objective To estimate the serotype and age-specific hospitalization burden associated with hand,foot and mouth disease (HFMD) in Anhua county of Hunan province,between October 2013 and September 2016.Methods We collected hospitalization records of HFMD patients from 6 virological surveillance hospitals,and reimbursement records through new rural cooperative medical system from 23 township health centers to estimate the age-specific hospitalization burden of HFMD in Anhua.Combined with the results of virological surveillance,the serotype-specific hospitalization burden of HFMD in Anhua,was estimated.Results During the three years,it was estimated that 3 541 clinical diagnosed HFMD cases,including 3 146 laboratory-confirmed HFMD cases,were hospitalized in Anhua,but only one was diaguosed as being severe.The estimated average hospitalization rate was 723/100 000(95％C1:699/100 000-747/100 000) for clinical diagnosed HFMD and 642/100 000 (95％ CI:620/100 000-665/100 000) for laboratory-confirmed HFMD between October 2013 and September 2016.The cases caused by Cox A16 (208/100 000) and Cox A6 (202/100 000) had higher hospitalization rates compared with the cases caused by EV71 (130/100 000),Cox A10 (38/100 000) and other enterovirus (64/100 000),and the difference was statistically significant (P＜0.001).HFMD-associated hospitalization rates peaked in children aged 1 year (3 845/100 000),and then decreased with age.Compared with the hospitalized HFMD caused by EV71 and Cox A16,Cox A6-associated hospitalizations mainly occurred in younger age groups (P＜0.001).Conclusion Our study revealed a substantial hospitalization burden associated with mild HFMD caused by EV71,Cox A16,Cox A6 and Cox A10,especially in young children,in Anhua.
RESUMO
Objective To estimate the serotype and age-specific hospitalization burden associated with hand,foot and mouth disease (HFMD) in Anhua county of Hunan province,between October 2013 and September 2016.Methods We collected hospitalization records of HFMD patients from 6 virological surveillance hospitals,and reimbursement records through new rural cooperative medical system from 23 township health centers to estimate the age-specific hospitalization burden of HFMD in Anhua.Combined with the results of virological surveillance,the serotype-specific hospitalization burden of HFMD in Anhua,was estimated.Results During the three years,it was estimated that 3 541 clinical diagnosed HFMD cases,including 3 146 laboratory-confirmed HFMD cases,were hospitalized in Anhua,but only one was diaguosed as being severe.The estimated average hospitalization rate was 723/100 000(95％C1:699/100 000-747/100 000) for clinical diagnosed HFMD and 642/100 000 (95％ CI:620/100 000-665/100 000) for laboratory-confirmed HFMD between October 2013 and September 2016.The cases caused by Cox A16 (208/100 000) and Cox A6 (202/100 000) had higher hospitalization rates compared with the cases caused by EV71 (130/100 000),Cox A10 (38/100 000) and other enterovirus (64/100 000),and the difference was statistically significant (P＜0.001).HFMD-associated hospitalization rates peaked in children aged 1 year (3 845/100 000),and then decreased with age.Compared with the hospitalized HFMD caused by EV71 and Cox A16,Cox A6-associated hospitalizations mainly occurred in younger age groups (P＜0.001).Conclusion Our study revealed a substantial hospitalization burden associated with mild HFMD caused by EV71,Cox A16,Cox A6 and Cox A10,especially in young children,in Anhua.
RESUMO
Objective To examine the incidence of metabolic syndrome (MS) in incipient female patients with rheumatoid arthritis (RA), and study the relationship between MS and disease activity of RA. Methods The clinical data of 102 incipient female RA patients (RA group) and 125 healthy controls (control group) were retrospectively analyzed. The incidence of MS was compared between 2 groups, and the clinical and laboratory data were analyzed between patients with MS and patients without MS. Results There were no statistical differences in age, body mess index (BMI), waist circumference, systolic blood pressure, diastolic blood pressure, fasting blood glucose (FBG), triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) between 2 groups (P>0.05). The incidences of waist circumference ≥ 80 cm, TG ≥ 1.70 mmol/L, HDL-C ≤ 1.30 mmol/L, MS according to the National Cholesterol Education Program Adult Treatment Panel Ⅲ (NCEP-ATPⅢ) standard and MS according to the Chinese Diabetes Society (CDS) standard in RA group were significantly higher than those in control group: 39.2% (40/102) vs. 25.6% (32/125), 37.3% (38/102) vs. 24.0%(30/125), 34.3%(35/102) vs. 21.6%(27/125), 34.3%(35/102) vs. 22.4%(28/125) and 27.5%(28/102) vs. 16.0% (20/125)%, and there were statistical differences (P0.05). The RA patients were divided into RA with MS (35 cases) and RA without MS (67 cases) according to the MS diagnostic standard of NCEP-ATPⅢ. The erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and blood uric acid in RA with MS patients were significantly higher than those in RA without MS patients:(68.1 ± 26.3) mm/h vs. (40.1 ± 30.6) mm/h, 4.260 mg/L vs. 1.505 mg/L and (330.5 ± 69.1)μmol/L vs. (269.0 ± 67.5)μmol/L, and there were statistical differences (P0.05). Conclusions The incidence of MS in incipient female patients with RA is higher than that in healthy controls, and RA patients are more prone to abdominal obesity, TG increasing and HDL-C decreasing. The inflammatory index and blood uric acid levels in RA with MS patients are significantly higher than those in RA without MS patients.
RESUMO
Objectives: Use antisense VEGF to reduce the immunosuppression induced by tumor and enhance the antithumor effect of IL-2. Methods: After the MMT45.Li murine liver cancer cells were modified with antisense VEGF alone, or antisense VEGF combined with IL-2 gene, the tumorigenesis of modified MM45T.Li was studied. The apoptosis of cancer cell induced by antisense VEGF and IL-2 gene in vivo was also studied. The tumors were cryosmeared 3 weeks after the mice bearing tumor were treated correspondingly with Ad-antiVEGF or Ad-Il-2 or Ad-antiVEGF/IL-2 or Ad-lacZ, the immunohistochemical analysis of CD4 + , CD8 + was performed.Results: The tumorigenesis of MM45T. Li was reduced by antisense VEGF, and the number of CD4 + , CD8 + cell was increased in tumor tissue, and the immunosupression was also reduced; At the same time antisense VEGF also enhanced the antithumor effect of IL-2 gene.Conclusions: Antisense VEGF not only can inhibit the neovascularization, but also can reduce the immunosupression induced by tumor, and improve lymphocyte infiltration toward tumor site;when it was combined with Il-2,anti VEGF can enhance the antitumor effect greatly.